Nicholas Hollmeyer Lynton Sells 6,464 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) insider Nicholas Hollmeyer Lynton sold 6,464 shares of Cardlytics stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $23,722.88. Following the completion of the transaction, the insider now owns 91,771 shares of the company’s stock, valued at $336,799.57. The trade was a 6.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Cardlytics Trading Down 1.4 %

NASDAQ CDLX opened at $3.44 on Wednesday. The firm’s fifty day moving average price is $3.90 and its 200 day moving average price is $4.78. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The company has a market capitalization of $174.83 million, a price-to-earnings ratio of -0.56 and a beta of 1.53.

Cardlytics (NASDAQ:CDLXGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The company had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same quarter last year, the company posted ($0.26) earnings per share. The business’s quarterly revenue was down 15.1% compared to the same quarter last year. On average, sell-side analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CDLX. Sanctuary Advisors LLC purchased a new position in shares of Cardlytics during the third quarter worth approximately $82,000. Barclays PLC boosted its stake in Cardlytics by 223.9% during the 3rd quarter. Barclays PLC now owns 58,026 shares of the company’s stock worth $186,000 after purchasing an additional 40,112 shares during the period. Geode Capital Management LLC grew its position in Cardlytics by 7.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after purchasing an additional 73,484 shares during the last quarter. Quadrature Capital Ltd acquired a new position in Cardlytics in the third quarter valued at $63,000. Finally, RBF Capital LLC raised its holdings in shares of Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock valued at $1,562,000 after buying an additional 369,620 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CDLX shares. Evercore ISI started coverage on shares of Cardlytics in a research note on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target for the company. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics currently has a consensus rating of “Hold” and a consensus target price of $6.92.

Get Our Latest Stock Analysis on CDLX

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.